“Reconnecting Brain to Body”: China trials groundbreaking brain chip to restore movement in paralyzed patients, marking a leap in neurotechnology

In the realm of modern medicine, the boundaries between science fiction and reality continue to blur. One of the most intriguing breakthroughs comes from China, where a pioneering brain chip is being used to restore movement in immobilized patients. Developed collaboratively by a public research institute and a state-backed startup, this innovation allows patients to control objects remotely without direct brain penetration. As these advancements unfold, China aims to lead the charge in the burgeoning field of neural interfaces, bringing hope to those who have long awaited such technological miracles.

The Advent of Semi-Invasive Brain Chips

China’s Beinao No.1 brain chip represents a significant leap in medical technology. Developed through a partnership between the Chinese Institute of Brain Research (CIBR) and NeuCyber NeuroTech, a public company, this device has been implanted in three paralyzed patients. The chip, placed on the brain’s surface without penetrating its tissue, reduces postoperative complications while slightly compromising signal quality compared to more invasive implants. Yet, the results have been promising.

As reported by the South China Morning Post, patients with paraplegia and hemiplegia have successfully controlled a robotic arm through thought alone, even transmitting words onto a screen. Using the same technology, researchers have enabled a patient with Charcot’s disease to communicate in Chinese by interpreting brain signals. Following these public demonstrations, the institute has been inundated with patient inquiries. In a bid to make this technology accessible, the Hubei province has set the cost of an invasive brain chip at 6,552 yuan, approximately 850 euros, significantly lower than Western estimates.

A Global Race to Implant the Most Patients

The development of Beinao No.1 is part of an intense global race. By the end of 2025, CIBR and NeuCyber aim to equip 13 patients, expanding to 50 by 2026, pending regulatory approval. This momentum positions China to potentially lead the world in the number of patients with brain chips. Currently, the American startup Synchron, backed by Jeff Bezos and Bill Gates, holds the record with ten treated patients across the United States and Australia.

Meanwhile, Elon Musk’s Neuralink offers a different approach with a fully inserted brain implant, promising superior signal resolution but with increased procedural risks. In February 2024, Neuralink implanted their device in a quadriplegic patient, Noland Arbaugh, who managed to play Mario Kart and Civilization using only his thoughts. To date, only three patients have undergone surgery with Neuralink’s technology, highlighting the competitive and high-stakes nature of this field.

Towards Commercializing the Medicine of Tomorrow?

China views brain-machine interfaces as a strategic lever to dominate future medicine. The government actively supports this burgeoning sector, considering national technical standards to reduce reliance on American models and establish global leadership. Founded in 2018, CIBR enjoys robust institutional backing. Its collaboration with NeuCyber NeuroTech, owned by the Zhongguancun Development Corporation (with over 1.2 billion euros in revenue in 2023), thrives in an ecosystem centered on public innovation.

While the Beinao No.1 project focuses on medical applications, it now seeks industrial partners to accelerate development. Interested companies must be visionary and willing to invest without immediate returns. The Beinao No.2 prototype, closer to Neuralink’s invasive approach, is already in development. Tested on a monkey in 2024, it allowed the animal to control a robotic arm via thought. Human trials could begin within 12 to 18 months, according to researcher Luo Minmin’s forecasts.

Implications and Future Directions

The advent of semi-invasive brain chips like Beinao No.1 raises profound implications for the future of healthcare and technology. As these devices become more prevalent, ethical considerations around accessibility, privacy, and consent emerge. The potential to restore mobility and communication for patients offers immense hope, but it also prompts questions about long-term effects and societal impacts.

As China and other nations race to refine and deploy these technologies, the landscape of medical treatment and human-computer interaction is set for a seismic shift. The integration of brain-machine interfaces could redefine how we perceive human potential and disability. As we stand on the cusp of this new era, one must ponder: What will the future hold for humanity as we continue to merge mind and machine?

Did you like it? 4.5/5 (24)